Future Health began in a single unit in the Faraday Building in Nottingham Science and Technology Park. This May, Future Health celebrates its 20th anniversary and has outgrown its small unit to comprise six subsidiaries in Europe and a global reach of 94 countries.
Organized by Save the Cord Foundation, World Cord Blood Day raises awareness of current and future uses of cord blood stem cells. To mark the occasion, the Foundation will host a free online conference on 17th November, welcoming parents, doctors, nurses and midwives.
A mother and father’s genes play a significant role in their baby’s development; from growth in the womb, to blood type. From pregnancy through to their adult life, your child’s blood type is one of the most important pieces of genetic information to be aware of.
Back in 2017, an initial study began to investigate whether infusions of cord blood can improve the symptoms of autism spectrum disorder (ASD) in young children. Following Phase I and Phase II trials, the results were revealed in the Journal of Pediatrics in June 2020.
A new clinical trial has been launched, investigating the potential treatment of Covid-19 symptoms with umbilical cord-derived MSCs (mesenchymal stem cells). The trial, which was given immediate authorization by the FDA, will take place on 24 Covid-19 patients.
